We explained to the shareholders what the problems were and how we were dealing with them. Our first problem was to try to negotiate our problem clinics out. Our second agenda is to restructure our purchases of clinics that were already made. We're doing so by developing a methodology of reselling their shares in two increments, based somewhat on performance, starting at six months and ending at another 18 months. So that the doctors who theoretically had no consideration will in fact have gotten what they bargained for.
Doctors are our most important component.
Well, once again, CliniCorp is a very small company at this point, relative to anything that we anticipated or that I've ever done. We believe it will get to be large. The number of shares gives us the flexibility to issue more stock. It gives us the ability to use those shares as we see fit. As we turn the company to profitability, the share price should respond.